Creatine Use and Muscle Stretching in Peripheral Artery Disease
Creatine Monohydrate Use and Muscle Stretching in Peripheral Artery Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Contact
Study Contact
- Name: Matthew Martenson, MS MPH
- Phone Number: (706) 296-1855
- Email: msm17b@my.fsu.edu
Study Contact Backup
- Name: Jacob Caldwell, Ph.D.
- Phone Number: 248-469-2058
- Email: jacob.caldwell@med.fsu.edu
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32304
- Florida State University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ankle-brachial index (ABI) of 0.90 or less in either leg or clinical diagnosis by a medical doctor (PAD group only)
- Stable condition for at least 3 months (PAD group only)
Exclusion Criteria:
- Habitual exercise or cardiovascular rehabilitation program during the past 3 months
- Critical limb ischemia
- Blow or above-knee amputation
- Leg pain at rest
- Major surgery or lower extremity revascularization in the last 3 months
- Major medical illness treatment during the prior 12 months
- Central neurological disease
- Limited ankle or knee joint range of motion
- Requirement of oxygen with activity or exercise
- Heart failure
- Atrial fibrillation
- Wheelchair confinement or inability to walk
- Cognitive disorder
- Vasculitis problems including Takayasu's arteritis, Berger's disease, collagen disease or Reynaud's disease
- Overt cardiovascular disease
- Metabolic disease
- Renal disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Creatine monohydrate
Creatine Monohydrate will be given at a 5 day loading period (10g/day) followed by a maintenance phase (5 g/day).
The objectives of the current trial are to investigate if creatine supplementation plus muscle stretching improves 6-minute walking distance and muscle oxygenation in patients with peripheral artery disease.
|
Creatine monohydrate will be used in combination with muscle stretching.
|
|
Placebo Comparator: Cellulose
These participants will consume a fiber supplement in place of creatine monohydrate at a matched dose with muscle stretching.
|
Cellulose will be used in combination with muscle stretching.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Walking Distance
Time Frame: Baseline and after 4 weeks of intervention
|
6-minute walking test.
This test measures the distance (in meters) that a patient can walk in 6 minutes.
|
Baseline and after 4 weeks of intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Percent Oxygenation/Seconds
Time Frame: Baseline and after 4 weeks of intervention
|
Near-infrared spectroscopy (NIRS) will be used to measure changes in oxygen saturation (%) in the gastrocnemius muscle.
Measurement will be the rate (slope) of the change in oxygen saturation (StO2) per second.
Thus rate of rate in oxygenation (slope) = StO2(%)/s = Δ StO2(%)/s
|
Baseline and after 4 weeks of intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Judy Muller-Delp, Ph.D., Professor
Publications and helpful links
General Publications
- Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. J Appl Physiol (1985). 1996 Jul;81(1):232-7. doi: 10.1152/jappl.1996.81.1.232.
- Hotta K, Behnke BJ, Arjmandi B, Ghosh P, Chen B, Brooks R, Maraj JJ, Elam ML, Maher P, Kurien D, Churchill A, Sepulveda JL, Kabolowsky MB, Christou DD, Muller-Delp JM. Daily muscle stretching enhances blood flow, endothelial function, capillarity, vascular volume and connectivity in aged skeletal muscle. J Physiol. 2018 May 15;596(10):1903-1917. doi: 10.1113/JP275459. Epub 2018 Apr 5.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Vascular Diseases
- Cardiovascular Diseases
- Atherosclerosis
- Arteriosclerosis
- Arterial Occlusive Diseases
- Peripheral Vascular Diseases
- Peripheral Arterial Disease
- Amino Acids, Peptides, and Proteins
- Organic Chemicals
- Carbohydrates
- Amino Acids
- Polymers
- Macromolecular Substances
- Biomedical and Dental Materials
- Manufactured Materials
- Technology, Industry, and Agriculture
- Polysaccharides
- Glucans
- Guanidines
- Amidines
- Biopolymers
- Cellulose
- Creatine
Other Study ID Numbers
Other Study ID Numbers
- 1150
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.